Hans Heemskerk

925 total citations
12 papers, 744 citations indexed

About

Hans Heemskerk is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Hans Heemskerk has authored 12 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Genetics. Recurrent topics in Hans Heemskerk's work include Muscle Physiology and Disorders (10 papers), RNA Interference and Gene Delivery (6 papers) and Virus-based gene therapy research (4 papers). Hans Heemskerk is often cited by papers focused on Muscle Physiology and Disorders (10 papers), RNA Interference and Gene Delivery (6 papers) and Virus-based gene therapy research (4 papers). Hans Heemskerk collaborates with scholars based in Netherlands and Italy. Hans Heemskerk's co-authors include Annemieke Aartsma‐Rus, Peter A.C. ’t Hoen, C.L. de Winter, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Gert‐Jan B. van Ommen, S. de Kimpe, Johan T. den Dunnen, Sjef J. de Kimpe and Begoña Aguilera and has published in prestigious journals such as Analytical Biochemistry, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Hans Heemskerk

12 papers receiving 728 citations

Peers

Countries citing papers authored by Hans Heemskerk

Since Specialization

Citations

This map shows the geographic impact of Hans Heemskerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Heemskerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Heemskerk more than expected).

Fields of papers citing papers by Hans Heemskerk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Heemskerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Heemskerk. The network helps show where Hans Heemskerk may publish in the future.

Co-authorship network of co-authors of Hans Heemskerk

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Heemskerk. A scholar is included among the top collaborators of Hans Heemskerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Heemskerk. Hans Heemskerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice 2013 ·The FASEB Journal ·Maaike van Putten, Margriet Hulsker, Courtney S. Young, Vishna Devi Nadarajah, Hans Heemskerk, Louise van der Weerd, Peter A.C. ’t Hoen, Gert‐Jan B. van Ommen, Annemieke Aartsma‐Rus	87
2	Peptide Conjugation of 2′- O -methyl Phosphorothioate Antisense Oligonucleotides Enhances Cardiac Uptake and Exon Skipping in mdx Mice 2013 ·Nucleic Acid Therapeutics ·(unknown), Hans Heemskerk, (unknown), (unknown), (unknown), (unknown), Anneke A. M. Janson, (unknown), (unknown), Peter A.C. ’t Hoen, J.C.T. van Deutekom, Begoña Aguilera, Annemieke Aartsma‐Rus	46
3	Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models 2012 ·Molecular Therapy — Nucleic Acids ·(unknown), Hans Heemskerk, (unknown), Maaike van Putten, Sjef J. de Kimpe, J. van Deutekom, Annemieke Aartsma‐Rus	30
4	Phage display screening without repetitious selection rounds 2011 ·Analytical Biochemistry ·Peter A.C. ’t Hoen, (unknown), (unknown), Erik Schultes, Begoña Aguilera, (unknown), Hans Heemskerk, Annemieke Aartsma‐Rus, (unknown), Johan T. den Dunnen	141
5	Prednisolone Treatment Does Not Interfere with 2′- O -Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy 2011 ·Human Gene Therapy ·Ingrid E.C. Verhaart, Hans Heemskerk, (unknown), Ingrid Kolfschoten, Anne Vroon, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Annemieke Aartsma‐Rus	14
6	Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model 2010 ·Molecular Therapy ·Hans Heemskerk, (unknown), (unknown), (unknown), Patrizia Sabatelli, Paola Rimessi, Paola Braghetta, Gert‐Jan B. van Ommen, S. de Kimpe, Alessandra Ferlini, Annemieke Aartsma‐Rus, Judith C. van Deutekom	114
7	Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy 2010 ·Laboratory Investigation ·Pietro Spitali, Hans Heemskerk, Rolf H. A. M. Vossen, Alessandra Ferlini, Johan T. den Dunnen, Peter A.C. ’t Hoen, Annemieke Aartsma‐Rus	34
8	Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy 2010 ·Laboratory Investigation ·Pietro Spitali, Hans Heemskerk, Rolf H. A. M. Vossen, Alessandra Ferlini, Johan T. den Dunnen, Peter A.C. ’t Hoen, Annemieke Aartsma‐Rus	3
9	Development of Antisense‐Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy 2009 ·Annals of the New York Academy of Sciences ·Hans Heemskerk, C.L. de Winter, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Annemieke Aartsma‐Rus	26
10	In vivo comparison of 2′‐O‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping 2009 ·The Journal of Gene Medicine ·Hans Heemskerk, C.L. de Winter, Sjef J. de Kimpe, Petra van Kuik‐Romeijn, (unknown), Gerard Platenburg, Gert‐Jan B. van Ommen, J.C.T. van Deutekom, Annemieke Aartsma‐Rus	135
11	Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms 2008 ·Molecular Therapy ·Annemieke Aartsma‐Rus, Laura Van de Vliet, Marscha Hirschi, Anneke A. M. Janson, Hans Heemskerk, C.L. de Winter, S. de Kimpe, (unknown), Peter A.C. ’t Hoen, Gert‐Jan B. van Ommen	112
12	Muscle binding peptides found by phage display as delivery agent for antisense oligonucleotides 2008 ·Journal of Controlled Release ·Hans Heemskerk, Begoña Aguilera, Annika Janson, (unknown), G J van Ommen, J. van Deutekom, Annemieke Aartsma‐Rus	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact